A report by Boston Consulting Group (BCG) and TalentX found that roles requiring human interaction and complex problem-solving are projected to grow despite AI advancements. The report identifies ten specific job categories expected to see increased demand, including AI and machine learning specialists, sustainability managers, and data scientists. These roles are considered complementary to AI, leveraging uniquely human skills. Why it matters: This analysis highlights the evolving nature of work in the age of AI, emphasizing the enduring value of human expertise in specialized and adaptive roles within the region's rapidly transforming economies.
Technology Innovation Institute (TII) and Burjeel Medical City (BMC) are partnering to develop novel immunotherapy solutions for cancer treatment, focusing on T-cell based therapeutics like CAR-T and TIL therapy. In the first phase, TII will construct a computational platform to identify patient-specific antigens from single-cell transcriptomics data, enabling the design of CAR-T cells. The two-year partnership aims to boost the body's immune system to fight cancer and personalize cancer therapies using TII's technologies. Why it matters: This collaboration signifies the UAE's commitment to advancing cancer care through collaborative research and innovative solutions, potentially establishing the country as a leader in personalized oncology treatments.
Boeing has inaugurated a new Research & Technology office at KAUST's Research and Technology Park, marking Boeing's first research center in a university within the GCC. The office will focus on R&D in aerospace technologies, building on Boeing's partnership with KAUST since 2009. Boeing is currently collaborating with KAUST on six major projects in areas like advanced materials and solar power. Why it matters: The establishment of this office signifies a deepened commitment to R&D in Saudi Arabia and the region, leveraging KAUST's resources to advance aerospace technologies.
Mani Sarathy, an associate professor of chemical engineering, has been appointed Associate Director of the Clean Combustion Research Center (CCRC) at KAUST. Sarathy is part of the University’s Physical Science and Engineering Division. The announcement did not detail specific research directions. Why it matters: This signals KAUST's continued investment in and focus on clean combustion research.
KAUST and King Faisal Specialist Hospital and Research Centre (KFSH&RC) are collaborating to develop bioelectronic sensors for rapid pathogen detection. These sensors aim to provide cheap and accurate results, potentially replacing conventional lab tests. A COVID-19 saliva test developed by KAUST researchers showed comparable sensitivity to PCR tests with a 15-minute turnaround. Why it matters: This partnership accelerates the development of novel diagnostic tools, which could improve healthcare accessibility in remote areas and low-income countries within the region.
KAUST hosted the KAUST Research Conference: Advances in Well Construction with Focus on Near-Wellbore Physics and Chemistry from November 7 to 9. The conference was co-chaired by Eric van Oort, a professor at UT Austin, and Tadeusz Patzek, director of the University’s Upstream Petroleum Engineering Research Center. Attendees included professors from the University of Queensland and UT Austin, and directors from GenesisRTS and Labyrinth Consulting Services, Inc. Why it matters: The conference facilitates international collaboration on advancements in petroleum engineering and well construction technologies, which are strategically important for Saudi Arabia.
KAUST's Bioscience Core Lab (BCL) supports regional and global health initiatives through industry partnerships, offering expertise and technology access to organizations like SaudiVax. BCL aids SaudiVax in developing vaccines and monoclonal antibodies tailored to the needs of Saudi Arabia and the MENA region, focusing on respiratory diseases like MERS and COVID-19. SaudiVax is also collaborating with KAUST to research a new preventative drug targeting SARS-CoV-2. Why it matters: This strengthens Saudi Arabia's capabilities in vaccine development and biomanufacturing, addressing critical healthcare needs in the region and reducing reliance on external sources.